
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

A recent longitudinal study published in Cardiovascular Diabetology highlights a significant link between the glucose disposal rate stroke risk and long-term metabolic health. Researchers examined how cumulative exposure to the estimated glucose disposal rate (eGDR) affects the incidence of stroke across various stages of cardiovascular-kidney-metabolic (CKM) syndrome. Given the rising prevalence of metabolic disorders in India, understanding these biomarkers is essential for preventive care.
The estimated glucose disposal rate (eGDR) serves as a reliable marker for peripheral insulin sensitivity. Specifically, clinicians calculate it using waist circumference, hypertension status, and HbA1c levels. In this study involving over 5,000 participants, scientists tracked eGDR levels over several years. Notably, they found that individuals with higher cumulative eGDR values enjoyed a much lower risk of developing a stroke. Consequently, maintaining high insulin sensitivity appears protective against cerebrovascular events. Moreover, the relationship remains consistent across all stages of CKM syndrome.
The research identified four distinct patterns of eGDR changes over time. Compared to those with persistently low eGDR, participants in the stable high group saw a 71% reduction in stroke risk. Furthermore, every 1-unit increase in cumulative eGDR was associated with a 5% reduction in stroke odds. These results confirm a linear inverse relationship. Therefore, monitoring long-term insulin sensitivity could provide better risk stratification for patients. Additionally, even those with a rapid decrease in eGDR showed lower risk than the persistent low group, suggesting that any period of higher sensitivity is beneficial.
Managing CKM syndrome requires a multi-faceted approach. Because eGDR is easy to calculate in clinical settings, it may serve as a valuable tool for identifying high-risk patients. Clinicians should focus on improving insulin sensitivity through lifestyle modifications and targeted therapies. By doing so, they may significantly reduce the long-term burden of stroke in metabolic patients. Similarly, routine monitoring of HbA1c and waist circumference can help track these changes effectively.
eGDR is a marker of insulin sensitivity. Higher levels indicate better metabolic health, which is directly linked to a lower risk of stroke in patients with cardiovascular-kidney-metabolic syndrome.
Researchers calculate eGDR using a specific formula involving waist circumference, the presence of hypertension, and HbA1c percentages to assess long-term metabolic exposure and cardiovascular risk.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

A 6-year study finds that higher cumulative glucose disposal rate (eGDR) is linked to a significantly lower risk of incident stroke in CKM syndrome patients...
3 months ago

Explore challenges and best practices in advance care planning for patients with multiple long-term conditions, including 2023 India legal updates....
Today

A study on the BIB-Pro platform demonstrates how clinical decision support systems improve the identification of psychosocial risks during pregnancy....
Today

A study shows that preoperative MSCT-derived pulmonary valve annulus z-scores, specifically below -2.62, predict early PR after Tetralogy of Fallot repair....
Today

This study reviews the clinical spectrum of cerebral palsy in Zambia, highlighting spastic subtypes, epilepsy comorbidities, and documentation needs....
Today

A study reveals that patients with active mucormycosis exhibit significantly reduced natural killer cell counts, indicating a distinct immunologic phenotype...
Today